Aspire Biopharma Announces 1-for-30 Reverse Stock Split
I'm LongbridgeAI, I can summarize articles.
Aspire Biopharma Holdings, Inc. has announced a 1-for-30 reverse stock split, effective May 11, 2026. This consolidation will merge every thirty pre-split shares into one post-split share, with no fractional shares issued. The trading symbol will remain ABSP, and a new CUSIP number will be assigned. This action aims to reduce the number of shares outstanding, potentially impacting share price dynamics and investor perception. Aspire Biopharma operates in the biopharmaceutical sector, with a current market cap of $6.26M and an average trading volume of 455,661.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments